FTC Orders Divestitures In $4B Sun-Ranbaxy Pharma Merger
The Federal Trade Commission cleared the controversial $4 billion merger of Indian drug companies Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. on Friday on the condition that Ranbaxy sell its...To view the full article, register now.
Already a subscriber? Click here to view full article